Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Sales	$ 1,172,601	$ 1,033,925	$ 3,314,663	$ 1,824,496
Cost of sales	883,143	841,414	2,416,417	1,415,068
Inventory write-down			263,404	576,772
Gross profit	289,458	192,511	634,842	(167,344)
Operating Expenses
Research and development and patents	656,764	878,303	2,558,648	3,108,312
General and administrative	1,374,095	1,412,727	4,036,784	4,438,083
Amortization and depreciation	54,767	50,689	164,833	148,786
Foreign exchange loss	48,156	2,733	36,717	79,287
Total operating expenses	2,133,782	2,344,452	6,796,982	7,774,468
Other Income (Expense)
Interest and other income	121,458	155,497	424,261	343,881
Loss before income taxes	(1,722,866)	(1,996,444)	(5,737,879)	(7,597,931)
Tax expense		(1,500)		(11,300)
Net loss for the period	$ (1,722,866)	$ (1,997,944)	$ (5,737,879)	$ (7,609,231)
Net loss per share for the period
Basic (in Dollars per share)	$ (0.18)	$ (0.6)	$ (0.82)	$ (3.53)
Weighted average outstanding common shares
Basic (in Shares)	9,612,973	3,328,191	6,961,938	2,156,283